Schedule 13G ownership disclosure
PDL BIOPHARMA INC
Security class unavailable · CUSIP: 69329Y104
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,413,409
- Percent of class
- 4.6100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001390777-15-000054
- Form type
- SC 13G
- Filer
- Bank of New York Mellon Corp
- CIK
- CIK 1390777
- Filed
- Feb 10, 2015
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership